价格

SARS-CoV-2 PLpro

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

CHIMERIC CONJUGATES FOR DEGRADATION OF VIRAL AND HOST PROTEINS AND METHODS OF USE
EP 4228699 A1申请人: DANA FARBER CANCER INST INC优先权: 2020
CN
EP
US
WO
4 件公开
PLPRO PROTEIN INHIBITOR, AND PREPARATION METHOD AND APPLICATION THEREOF
US 20250289826 A1申请人: UNIV TSINGHUA优先权: 2022
CN
EP
US
WO
4 件公开
SULFONE-1H-PYRROLE-2-CARBOXAMIDE INHIBITORS OF SARS-COV-2 NSP14 METHYLTRANSFERASE AND DERIVATIVES THEREOF
EP 4654964 A1申请人: UNIV ROCKEFELLER优先权: 2023
EP
US
WO
3 件公开
PLPRO INHIBITORS
US 20250059159 A1申请人: SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD优先权: 2021
CN
US
2 件公开
PROTACS TARGETING VIRAL ENZYMES FOR PRECISE TREATMENT OF COVID-19
US 20260166160 A1申请人: OHIO UNIV优先权: 2022
US
WO
2 件公开
Application of PLpro protein inhibitor in medicines for treating or preventing novel coronavirus infection
CN 112022855 A申请人: UNIV PEKING SHENZHEN GRADUATE SCHOOL优先权: 2020
CN
2 件公开
Application of pirfenidone or pharmaceutically acceptable salt thereof in preparation of medicine for preventing and/or treating novel coronavirus inflammation
CN 111481547 A申请人: MARINE BIOMEDICAL RES INST QINGDAO CO LTD优先权: 2020
CN
一种抗病毒化合物及其制备方法和应用
- CN 114957165 B
  申请人: 清华大学优先权: 2021
  CN
- CN 114957110 B
  申请人: 清华大学优先权: 2021
  CN
TRYPTANTHRIN DERIVATIVES WITH THIOSEMICARBAZONE SUBSTITUTION AND USE THEREOF
US 20250171449 A1申请人: UNIV KARLOVA优先权: 2022
US
COMPOSITIONS AND METHODS FOR INHIBITING PLpro PROTEASE ACTIVITY AND FOR PREVENTING AND TREATING SARS-CoV-2 INFECTION
US 2024325321 A1申请人: UNIV ARIZONA优先权: 2022
US

药物

SARS-CoV-2 PLpro

专利

一种抗病毒化合物及其制备方法和应用